Looking for biologic drug patents? See BiologicPatentWatch.com

DrugPatentWatch

About DrugPatentWatch

Pharmaceutical Industry Intelligence

DrugPatentWatch was founded in 2002, and originally focused on meeting the needs of investors seeking transparency around drug patent expiration dates. The scope of DrugPatentWatch has expanded significantly in the years since inception.

Use cases for the database include:

  • Branded pharmaceutical firms seeking competitive intelligence
  • Generic and API manufacturers seeking knowledge of which drugs to develop
  • Wholesalers seeking advance notice of patent expiry to avoid over-stocking off-patent drugs
  • Healthcare payers seeking to project and manage future budgets

Different plans are available to meet the needs of these diverse audiences.

Revisions and Annual Editions

DrugPatentWatch incorporates many data sources. Each is updated as frequently as possible, providing you with fresh information.

The core data are updated monthly, using feeds directly from the FDA and USPTO. Sales information is updated annually. The accessory data, such as tentative approvals, US patent details, internaional patent information, etc., are updated weekly. Clinical trial and Paragraph IV data are updated daily.

Annual editions — available in the Premium and Ultimate plans — provide historic archives of the state of drug patent expirations in each recorded year.

Database Coverage

DrugPatentWatch contains information on FDA-approved small molecule drugs.

For information on biologics see DrugPatentWatch's sister site, BiologicPatentWatch.com

Development

DrugPatentWatch is developed by Yali Friedman, Ph.D.

Dr. Friedman is also chief editor and publisher of the Journal of Commercial Biotechnology, and author of Building Biotechnology, which is used as a course text in dozens of biotechnology programs. He is also a member of the board of directors of AmericasHealth, serves on the science advisory board of Chakra Biotech, is an associate of the World Technology Network, and has also served as a judge for the Biotech Humanitarian Award and the Maryland Incubator Company of the Year Award.

Dr. Friedman has strong exposure to leading issues in international biotechnology. He is editor of the Scientific American worldVIEW scorecard, a global biotechnology perspective profiling biotechnology industries and innovation capacity in dozens of countries, and has been invited to participate in biotechnology industry development forums for international groups such as APEC, in Europe, and throughout Asia.

Do you have needs beyond DrugPatentWatch's current offerings? Please send them to admin@DrugPatentWatch.com

Contact Information

Sales information
sales@DrugPatentWatch.com
General inquiries or account issues   admin@DrugPatentWatch.com
Group discounts Discount schedule
Regional Sales Partners
India / South Asia
Bharat Book Company
810, Real Tech Park,
8th Floor, Sector - 30A,
Vashi, Navi Mumbai - 400703 , INDIA.
Phone : +91 22 27810772, 27810773
info@bharatbook.com

DrugPatentWatch is a product of:
ThinkBiotech LLC
3909 Witmer Rd #416
Niagara Falls, NY 14305
Connect on LinkedIn

Sign up for a free trial

No commitment, no credit card required
First name
Last name
Email address

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology

`abc